Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue. Merck & Co. was originally established as the American affiliate of Merck Group in 1891. Merck develops and produces medicines, vaccines, biologic therapies and animal health products. It has several blockbuster products, including cancer immunotherapy, anti-diabetic medications, and vaccines for HPV and chickenpox, each generating significant revenue as of 2020. The company is ranked 71st on the 2022 Fortune 500 and 87th on the 2022 Forbes Global 2000, both based on 2021 revenues. In 2023, the company’s seat in the Forbes Global 2000 was 73.
CEO
Robert M. Davies
FOUNDED
1 January 1891
HEADQUARTERS
San Francisco, California United States
WEBSITE
merck.com
NUMBER OF EMPLOYEES
74,000
SECTOR
Healthcare
INDUSTRY
Drug Manufacturers – General
Index
DJIA, S&P 500
Market Cap
190.06B
Income
17.43B
Sales
63.78B
Book/sh
19.21
Cash/sh
3.72
Dividend Est.
3.14 (4.15%)
Dividend TTM
3.16 (4.17%)
Dividend Ex-Date
Jun 16, 2025
Employees
75000
Option/Short
Yes / Yes
Sales Surprise
1.24%
SMA20
-2.93%
P/E
11.02
Forward P/E
7.79
PEG
0.95
P/S
2.98
P/B
3.94
P/C
20.37
P/FCF
11.15
Quick Ratio
1.16
Current Ratio
1.41
Debt/Eq
0.72
LT Debt/Eq
0.69
EPS Surprise
4.09%
SMA50
-7.24%
EPS (ttm)
6.87
EPS next Y
9.72
EPS next Q
2.06
EPS this Y
16.40%
EPS next Y
9.16%
EPS next 5Y
11.66%
EPS past 5Y
12.04%
Sales past 5Y
7.14%
EPS Y/Y TTM
654.93%
Sales Y/Y TTM
4.40%
EPS Q/Q
7.20%
Sales Q/Q
-1.20%
SMA200
-22.44%
Insider Own
0.07%
Insider Trans
-0.19%
Inst Own
80.26%
Inst Trans
-0.49%
ROA
15.78%
ROE
39.31%
ROI
21.31%
Gross Margin
74.68%
Oper. Margin
34.71%
Profit Margin
27.33%
Payout
46.32%
Earnings
Apr 24 BMO
Trades
904
Shs Outstand
2.52B
Shs Float
2.51B
Short Float
1.64%
Short Ratio
2.49
Short Interest
41.27M
52W Range
73.31 – 134.63
52W High
-43.78%
52W Low
3.25%
RSI (14)
40.87
Recom
1.88
Rel Volume
0.1
Avg Volume
16.57M
Volume
83,183
Perf Week
-1.68%
Perf Month
-10.65%
Perf Quarter
-16.44%
Perf Half Y
-23.68%
Perf Year
-41.55%
Perf YTD
-23.91%
Beta
0.4
ATR (14)
2.19
Volatility
1.22% 2.51%
Target Price
102.1
Prev Close
76.17
Price
75.69
Change
-0.63%
Information edited and updated on 29/05/2025
KEY FINANCIALS
Institutional Ownership
VANGUARD GROUP INC
10.00%
BlackRock, Inc.
8.92%
Hudson Bay Capital Management LP
4.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC
3.29%
GEODE CAPITAL MANAGEMENT, LLC
2.36%
ZAZOVE ASSOCIATES LLC
2.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
1.95%
MORGAN STANLEY
1.71%
FMR LLC
1.26%
NORTHERN TRUST CORP
1.20%
Insider Trading
Insider Trading Volume
Income Statement
Period
TTM
FY 2024
FY 2023
Period End Date
—
12/31/2024
12/31/2023
Period Length
12 Months
12 Months
12 Months
Total Revenue
63,783.00
63,973.00
59,871.00
Cost of Goods Sold Incl. D&A
16,147.00
16,802.00
15,977.00
Gross Profit
47,636.00
47,171.00
43,894.00
Selling, General and Administrative Excl. Other
25,498.00
26,566.00
40,912.00
Research and Development
15,366.00
15,833.00
30,530.00
Other Operating Expense
0.00
0.00
0.00
Operating Income
22,138.00
20,605.00
2,982.00
Interest Expense
1,281.00
1,271.00
1,146.00
Unusual Expense
2,152.00
1,140.00
1,029.50
Net Income Before Taxes
20,169.00
19,936.00
1,889.00
Income Taxes
2,717.00
2,803.00
1,512.00
Consolidated Net Income
17,452.00
17,133.00
377.00
Net Income From Continuing Operations
17,434.00
17,117.00
365.00
Net Income
17,434.00
17,117.00
365.00
EPS (Recurring)
7.48
7.05
0.43
EPS (Basic, Before Extraordinaries)
6.89
6.76
0.14
EPS (Diluted)
6.87
6.74
0.14
EBITDA
26,684.00
25,104.00
6,854.00
Non-Operating Income (Expense)
1,464.00
1,742.00
1,082.50
Other After Tax Adjustments
0.00
0.00
0.00
Stock Option Compensation Expense
570.38
644.00
549.00
Price To Earnings Ratio
11.09
11.09
20.60
Price To Sales Ratio
3.56
3.95
4.64
Gross Margin
74.68
73.74
73.31
Operating Margin
34.71
32.21
4.98
Net Margin
27.33
26.76
0.61
Shares Outstanding
2,516.08
2,527.64
2,531.63
Market Capitalization
191,265.16
191,265.16
248,840.69
values in Millions, USD
Balance Sheet
Period
FY 2024
FY 2023
Period End Date
12/31/2024
12/31/2023
Cash & Short Term Investments
13,765.00
7,161.00
Short Term Receivables
11,127.00
11,072.00
Inventories
6,109.00
6,358.00
Other Current Assets
7,781.00
7,577.00
Total Current Assets
38,782.00
32,168.00
Net Property, Plant & Equipment
25,149.00
24,488.00
Total Investments and Advances
1,676.00
1,584.00
Long-Term Note Receivable
—
—
Intangible Assets
38,038.00
39,208.00
Deferred Tax Assets
—
—
Other Assets
13,461.00
9,227.00
Total Assets
117,106.00
106,675.00
Short Term Debt Incl. Current Port. of LT Debt
2,931.00
1,657.00
Accounts Payable
4,079.00
3,922.00
Income Tax Payable
3,914.00
2,649.00
Other Current Liabilities
17,496.00
17,466.00
Total Current Liabilities
28,420.00
25,694.00
Long Term Debt
35,339.00
34,611.00
Provision for Risks Charges
939.00
1,231.00
Deferred Tax Liabilities
1,387.00
871.00
Other Liabilities
4,649.00
6,633.00
Total Liabilities
70,734.00
69,040.00
Non-Equity Reserves
0
0
Preferred Stock – Carrying Value
0
0
Common Equity
46,313.00
37,581.00
Total Shareholders Equity
46,313.00
37,581.00
Accumulated Minority Interest
59
54
Total Equity
46,372.00
37,635.00
Total Liabilities & Stockholders Equity
117,106.00
106,675.00
Book Value Per Share
18.32
14.84
Tangible Book Value Per Share
3.27
-0.64
Full-Time Employees
75,000
72,000
Price to Book Ratio
3.96
5.6
Return on Assets
15.3
0.34
Return on Equity
40.81
0.87
Return on Invested Capital
20.96
0.51
Quick Ratio
1.15
1
Current Ratio
1.36
1.25
values in Millions, USD
Cash Flow
Period
TTM
FY 2024
FY 2023
Period End Date
—
12/31/2024
12/31/2023
Period Length
12 Months
12 Months
12 Months
Net Income
17,451.00
17,133.00
377.00
Depreciation
4,614.00
4,499.00
3,872.00
Other Funds (Non Cash)
4,194.00
4,752.00
12,861.00
Funds from Operations
24,875.00
25,135.00
15,211.00
Extraordinary Item
0.00
0.00
0.00
Changes in Working Capital
-3,997.00
-3,667.00
-2,205.00
Income Taxes Payable
—
1,023.00
214.00
Cash from Operating Activities
20,878.00
21,468.00
13,006.00
Capital Expenditures
-3,839.00
-3,372.00
-3,863.00
Net Assets From Acquisitions
-3,347.00
-4,093.00
-12,032.00
Sale of Fixed Assets and Businesses
0.00
0.00
0.00
Purchase or Sale of Investments
-526.00
-142.00
703.00
Purchase of Investments
-1,099.00
-519.00
-955.00
Sale Or Maturity of Investments
573.00
377.00
1,658.00
Other Uses
-133.00
-127.00
-36.00
Other Sources
0.00
0.00
1,145.00
Cash from Investing Activities
-7,845.00
-7,734.00
-14,083.00
Cash Dividends Paid
-7,940.00
-7,840.00
-7,445.00
Change in Capital Stock
-2,239.00
-1,129.00
-1,221.00
Repurchase of Common Pref Stock
-2,348.00
-1,306.00
-1,346.00
Sale of Common Pref Stock
109.00
177.00
125.00
Proceedsfrom Stock Options
0.00
0.00
0.00
Issuance or Reduction of Debt, Net
560.00
2,309.00
4,184.00
Change in Long Term Debt
560.00
2,309.00
4,184.00
Issuance of Long Term Debt
3,599.00
3,599.00
5,939.00
Reduction of Long Term Debt
-3,039.00
-1,290.00
-1,755.00
Net Financing Active Other Cash Flow
-354.00
-372.00
-328.00
Other Financing Activities Uses
-354.00
-372.00
-328.00
Cash from Financing Activities
-9,973.00
-7,032.00
-4,810.00
Exchange Rate Effect
1
-293
23
Net Change in Cash
3,061.00
6,409.00
-5,864.00
Free Cash Flow
17,039.00
18,096.00
9,143.00
Preferred Dividends (Cash Flow)
—
0
0
Price to Free Cash Flow
24.97
24.65
163.53
values in Millions, USD
Merck & Co Inc at a Glance
Merck & Co Inc Financials at a glance including: EPS, Sales, Shares Outstanding, SPY Comparison, Short Interest, Short Interest History, EPS Performance and Forecast, GAAP EPS Performance and Forecast, Revenue Performance and Forecast, Price Reactions to Earnings Reports, Latest Revisions, Revenue by Products and Services, Revenue by Regions, Revenue by Segment, Dividends, and Dividend Payout History.
Please Note: Information edited and updated on 29/05/2025
Index – Major index membership
Market Cap – Market capitalization
Income – Trailing 12 months income
Sales – Trailing 12 months revenue
Book/sh – Most recent quarter book value a share
Cash/sh – Most recent quarter cash per share
Dividend Est. – Analysts’ dividend estimate (fiscal year)
Dividend TTM – Trailing 12-month dividend
Dividend Ex-Date – Ex-dividend date
Employees – Number of full-time employees
Option/Short – Stock has options on a market exchange/stock is available to sell short
Sales Surprise – Last quarter revenue surprise
SMA20 – Stock price distance from 20-day simple moving average
P/E – Price-to-Earnings (trailing 12-months)
Forward P/E – Forward Price-to-Earnings (next fiscal year)
PEG – Price-to-Earnings-to-Growth
P/S – Price-to-Book (most recent quarter)
P/B – Price-to-Book (most recent quarter)
P/C – Price to cash per share (most recent quarter)
P/FCF – Price to Free Cash Flow (trailing 3-months)
Quick Ratio – Quick Ratio (most recent quarter)
Current Ratio – Current Ratio (most recent quarter)
Debt/Eq – Total Debt to Equity (most recent quarter)
LT Debt/Eq – Long Term Debt to Equity (most recent quarter)
EPS Surprise – Last quarter Earnings-Per-Share surprise
SMA50 – Stock price distance from 50-Day Simple Moving Average
EPS (ttm) – Diluted Earnings-Per-Share (trailing 3-months)
EPS next Y – Earnings-Per-Share estimate for next year
EPS next Q – Earnings-Per-Share estimate next quarter
EPS this Y - Earnings-Per-Share growth this year
EPS next Y - Earnings-Per-Share estimate for next year
EPS next 5Y – Long term annual growth estimate (5 years)
EPS past 5Y – Annual Earnings-Per-Share growth past 5 years
Sales past 5Y – Annual sales growth past 5 years
EPS Y/Y TTM – Earnings-Per-Share growth (trailing 3 months)
Sales Y/Y TTM – Sales growth (trailing 3 months)
EPS Q/Q – Quarterly earnings growth (Year-on-Year)
Sales Q/Q – Quarterly revenue growth (Year-on-Year)
SMA200 – Stock price distance from 2-Day Simple Moving Average
Insider Own – Percentage insider ownership of company shares
Insider Trans – Insider transactions (6-month change in Insider Ownership)
Inst Own – Institutional ownership
Inst Trans - Institutional transactions (3-month change in Institutional Ownership)
ROA – Return on Assets (trailing 3-months)
ROE – Return on Equity (trailing 3-months)
ROI – Return on Investment (trailing 3-months)
Gross Margin – Gross Margin (trailing 3-months)
Oper. Margin – Operating Margin (trailing 3-months)
Profit Margin – Net Profit Margin (trailing 3-months)
Payout – Dividend Payout Ratio (trailing 3-months)
Earnings – BMO = Before Market Open / AMC = After Market Close
Shs Outstand – Shares outstanding
Shs Float – Shares float
Short Float – Short interest share
Short Ratio – Short interest ratio
Short Interest – Short interest
52W Range – 52-Week trading range
52W High – Distance from 52-Week High
52W Low - Distance from 52-Week Low
RSI (14) – Relative Strength Index
Perf Week – Performance (Week)
Perf Month – Performance (Month)
Perf Quarter – Performance (Quarter)
Perf Half Y - Performance (Half Year)
Perf Year – (Year)
Perf YTD - Performance (Year-To-Date)
Beta - Beta
ATR (14) – Average True Range
Volatility – Volatility (Week, Month)
Target Price – Analysts’ mean target price
Price – Current stock price
